or
forgot password
  • cancer clinical trials in lubbock, TX

  • Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Sarcoma
    Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Sarcoma
    Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Colorectal Cancer
    Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Pancreatic Cancer
    Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Brain Tumor, Central Nervous System Tumor
    S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Lung Cancer
    S9832: Effectiveness of Telephone Counseling By Breast Cancer Survivors on the Well-Being of Women With Recurrent Breast Cancer
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
    Melatonin and Radiation Therapy in Treating Patients With Brain Metastases
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Metastatic Cancer, Radiation Toxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Arsenic Trioxide in Treating Men With Germ Cell Cancer
    Southwest Cancer and Research Center at University Medical Center
    Lubbock, Texas 79415-3364
    Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Carcinoma of Unknown Primary
    Prialt (Ziconotide) In Severe Chronic Pain
    Texas Tech University HSC
    Lubbock, Texas 79430
    Pain
    Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma
    Joe Arrington Cancer. Research & Treatment Center
    Lubbock, Texas 79410
    Melanoma
    Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific
    Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Pancreatic Cancer
    S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Cervical Cancer
    Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Metastatic Cancer, Sarcoma
    Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor
    S0222: Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer
    UMC Southwest Cancer and Research Center
    Lubbock, Texas 79415-3364
    Lung Cancer
    Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    UMC Southwest Cancer and Research Center
    Lubbock, Texas 79415-3364
    Pancreatic Cancer
    Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain
    International Pain Institute
    Lubbock, Texas 79413
    Pain
    Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Brain and Central Nervous System Tumors
    Study of ILX651 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Carcinoma
    Joe Arrington Cancer Center
    Lubbock, Texas 79410
    Non-Small-Cell Lung Carcinoma
    Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel
    Joe Arrington Cancer Center
    Lubbock, Texas 79410
    Hormone-Refractory Prostate Cancer
    MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Melanoma, Metastases
    Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy
    UMC Southwest Cancer and Research Center
    Lubbock, Texas 79415-3364
    Gestational Trophoblastic Tumor
    S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
    UMC Southwest Cancer and Research Center
    Lubbock, Texas 79415-3364
    Head and Neck Cancer
    A Multiple Myeloma Trial in Patients With Bone Metastases
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Multiple Myeloma
    Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Breast Neoplasm
    Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Carcinoma, Non-Small-Cell Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Texas Tech University Health Sciences Center
    Lubbock, Texas 79430
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Brain and Central Nervous System Tumors
    Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Neuroblastoma
    Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Colorectal Cancer
    Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia
    Joe Arrington Cancer Center
    Lubbock, Texas 79410
    B-Cell Chronic Lymphocytic Leukemia (B-CLL)
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    Covenant Children's Hospital
    Lubbock, Texas 79410
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
    Covenant Medical Center-Lakeside
    Lubbock, Texas 79410
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Safety and Efficacy of Angiotech Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access
    Texas Tech University Health Sciences Center
    Lubbock, Texas 79430
    Kidney Diseases, ESRD
    Assessment and Tracking of Long-term Alefacept Safety
    Lubbock Dermatology and Skin Cancer Center
    Lubbock, Texas 79410
    Psoriasis
    Phase 1 Study of EZN-2968 Weekly in Adult Patients With Advanced Solid Tumors or Lymphoma
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Carcinoma, Lymphoma
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Leukemia
    Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)
    Southwest Cancer Treatment and Research Center
    Lubbock, Texas 79415
    Lung Cancer, Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung
    Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer
    Sanofi-Aventis Investigational Site Number 840017
    Lubbock, Texas 79415
    Urinary Bladder Neoplasms
    Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis
    Texas Tech University Health Sciences Center
    Lubbock, Texas 79430
    Severe Sepsis
    Cognition in the Study of Tamoxifen and Raloxifene
    Joe Arrington Cancer Research and Treatment Center

    Trial Locations
    Joe Arrington Cancer Research and Treatment Center
    Southwest Cancer Center
    Cognition, Aging
    Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
    Joe Arrington Cancer Center

    Trial Locations
    Joe Arrington Cancer Center
    Texas Tech University Health Sciences Center
    Acute Myeloid Leukemia